Esophageal Cancer Whole Exome Sequencing (WES) Data
Collection date
2019-04-03
Sample Type
Cohort
Description
Retrospectively collected adjacent and tumor samples from 30 esophageal cancer patients were subjected to whole-exome sequencing. Additionally, multiplex immunofluorescence staining was performed on patient tissue sections. The study found that, compared to patients with wild-type NOTCH1, those with NOTCH28-mutant esophageal cancer exhibited significantly lower proportions of B cells and neutrophils in their tumor tissues.
